Skip to main content

Funding Opportunities

Vanderbilt-Ingram Cancer Center regularly solicits applications for pilot funding to support basic, translational, clinical or collaborative cancer research. Pilot funds allow investigators to collect preliminary data to support an application for independent research support through extramural, peer-reviewed funding. Over the past five years, the Cancer Center awarded $4.1 million to fund 98 pilot projects. This investment led to the acquisition of more than $41 million in extramurally funded grants – a 985 percent return on investment.

Calls for proposals are distributed throughout the year by email, online, and in campus publications. Award amounts and submission deadlines vary. All pilot project awards are funded for one-year periods.

For more information, contact us at vicc.fundingopportunity@vumc.org

VICC Multi-Tier Developmental Research Funding

Complete an online application to apply for this funding

Submit Your Proposal

 

Complete this online application to apply for pilot funding

Funding Sources

Source Eligibility Funding Cycle Amount Principal Investigator
Multi-Tier Developmental Research Funding Vanderbilt-Ingram Cancer Center members only Variable Three Tiers Jennifer Pietenpol, Ph.D.
American Cancer Society-Institutional Research Grants (ACS-IRG) Open to junior faculty in any school/department at Vanderbilt University Spring & Fall up to $30,000 David Cortez, Ph.D
Cancer Center Support Grant (CCSG) Vanderbilt-Ingram Cancer Center members only Variable up to $35,000  Jennifer Pietenpol, Ph.D.
Breast SPORE Tenured and tenure-track faculty at Vanderbilt or Meharry Medical College with membership in the Vanderbilt-Ingram Cancer Center Variable

up to $50,000

Jennifer Pietenpol, Ph.D.; Ingrid Mayer, M.D., M.S.C.I.
GI SPORE DRP Tenured and tenure-track faculty at Vanderbilt, Meharry Medical College or Tennessee State University with membership in the Vanderbilt-Ingram Cancer Center Variable up to $50,000 Robert Coffey, M.D.
GI SPORE CEP The GI SPORE Career Enhancement Program solicits applications yearly from investigators at Vanderbilt, Meharry Medical College or Tennessee State University.  Variable up to $50,000 Robert Coffey, M.D.
Thoracic Program Tenured and tenure-track faculty at Vanderbilt or Meharry Medical College with membership in the Vanderbilt-Ingram Cancer Center Variable $25,000 to $50,000 Pierre Massion, M.D.
Hematology Helping Hands Fund (HHHF) Vanderbilt-Ingram Cancer Center members only Variable $10,000 to $20,000 Michael Savona, M.D.
VICC Ambassadors Junior faculty at Vanderbilt Fall $50,000 Scott Hiebert, Ph.D. 

 

American Cancer Society-Institutional Research Grants

The American Cancer Society (ACS)-Institutional Research Grant (IRG) is the major source of support at Vanderbilt University for young investigators building cancer research programs. These funds provide seed money to support junior faculty members with an interest in cancer research who do not have national grant support of their own or who have not received prior support from the IRG. The ACS defines junior faculty as investigators at the rank of assistant professor or equivalent who are eligible to apply as a principal investigator for grant support from national agencies. Eligible investigators must be within six years of their first independent faculty appointment. Awards are made for a one-year project period and the maximum allocation is limited to $30,000. If sufficient progress has been made toward the project goals, IRG support may be renewed for an additional year. Funds are available to all schools at Vanderbilt University.

Back to 'Funding Sources'

 

Cancer Center Support Grant Pilot Projects

Funding provided by the Cancer Center Support Grant (CCSG) supports several types of pilot projects (1) highly innovative pilot projects focusing on proof-of-concept or translational research; (2) preliminary collaborative investigations that lead to multi-investigator grant awards or clinical trial; (3) projects that closely align with the Cancer Center's strategic plan and enhance key initiatives; and (4) pilot funding for junior investigators to jump-start independent projects or for more senior investigators looking to study a novel idea derived from discovery.

Back to 'Funding Sources'

 

SPORE Pilot Projects

The Breast SPORE Developmental Research Program provides pilot funding to promote excellent translational research in breast cancer. These funds allow early, high-risk research to move solid basic science findings toward clinical application, as well as the migration of provocative clinical observations back to the laboratory in order to understand their mechanistic basis. Main criteria for selection and funding of developmental (pilot) projects include scientific merit, relevance to mammary biology and/or breast cancer, collaboration and potential for extramural peer-reviewed funding. There also is an emphasis on utilization of emerging technologies and on young investigators.

Current Opportunity: Breast SPORE DRP and CEP

The GI SPORE Developmental Research Program solicits applications once a year in the spring from investigators at Vanderbilt, Meharry Medical College or Tennessee State University. Proposals are reviewed for scientific merit and the likelihood of leading to extramural funding. Special emphasis is placed on attracting young investigators into GI cancer research, high risk/high gain projects, and emerging technologies and their application to GI cancer research. Award amounts of up to $50,000 per project per year are available.

Current Opportunity:  GI SPORE Pilot Project Funding

The GI SPORE Career Enhancement Program solicits applications yearly from investigators at Vanderbilt, Meharry Medical College or Tennessee State University. Proposals are reviewed for scientific merit and the likelihood of leading to extramural funding. Special emphasis is placed on attracting young investigators into GI cancer research, high risk/high gain projects, and emerging technologies and their application to GI cancer research. Award amounts of up to $50,000 per project per year are available.

Current Opportunity:  GI SPORE Career Enhancement Program Funding

Back to 'Funding Sources'

 

Thoracic Program

The Thoracic Program provides pilot funding for the conduct of basic, translational, or clinical research on the cause, prevention, detection, control, or treatment of lung cancer. Funds support projects from individual investigators or collaborative teams. Original cancer-related projects with the potential to develop into independent R01 grants are encouraged. Current Pilot Project awardees are eligible to apply for an additional year of funding. Grants from $25,000 to $50,000 in total costs are awarded for a one-year period.

Back to 'Funding Sources'

 

Hematology Helping Hands Fund

The Hematology Helping Hands Fund was started in 2007 at the request of philanthropic donors to provide financial aid for patients undergoing stem cell transplant. The program has evolved over the last eight years and now allows for 25 percent of the funds to be used for research projects. RFAs are distributed to cancer center members. Applications are peer reviewed and awards in the range of $10,000 to $20,000 per awardee are granted. In addition, important pilot projects which are aligned with cancer center mission and felt to be at high yield for federal funding are supported.

Back to 'Funding Sources'

 

VICC Ambassadors

The VICC Ambassadors are the next generation of philanthropists committed to winning the battle against cancer by awarding Discovery Grants to promising young researchers at the Vanderbilt-Ingram Cancer Center. Discovery Grants allow skilled researchers to pursue exciting discoveries in basic and clinical science—aiding our understanding of disease processes and leading to better methods of prevention, diagnosis and treatment. For Vanderbilt physicians and scientists this funding not only yields early results, it helps develop the ideas that grow to large federally funded projects aimed at transformative breakthroughs in care. Three grants of $50,000 each are awarded every fall.

Back to 'Funding Sources'

 

Other Funding Resources

NIH-SBIR Concept Award
NCI SBIR encourages small businesses developing highly innovative and transformative technologies that have the potential to create new scientific paradigms, establish entirely new and improved approaches to significantly improve cancer research, prevention, detection and care in pediatric and/or rare cancers to apply for the NCI SBIR Innovative Concept Award.
Additional Details
July 23, 2021

ASCO/Pfizer Conquer Cancer- Equitable Care of Metastatic Breast Cancer Patients Research Grant Program
Conquer Cancer, the ASCO Foundation and Pfizer Global Medical Grants are collaborating to offer a research grant funding opportunity to promote the advancement of scientific knowledge concerning equitable care of metastatic breast cancer (mBC) patients. This research grant program will employ data-driven frameworks to define and address inequities in the delivery of care and outcomes for patients of color with metastatic breast cancer. This program is aligned with the theme of the 2021 ASCO Annual Meeting; Equity: Every Patient. Every Day. Everywhere.
Additional Details
August 4, 2021

Elsa U. Pardee Foundation
lsa U. Pardee Foundation grants are devoted to cancer research with about $110.5 million given to over 300 different institutions across the United States since 1944. Initially, ongoing research programs at well-known cancer institutes such as Memorial Sloan-Kettering took center stage. By the 1950s, however, the Foundation’s trustees recognized a critical oversight: new scientists with cutting-edge ideas were often denied private and government funding simply because they were unknown. The Elsa U. Pardee Foundation boldly broke tradition by considering their grant proposals and funding the most innovative approaches to conquering cancer – a practice which continues to set this Foundation apart. As the proposals grew more complex, the Foundation formed a Medical Committee of specialists to manage the process. Today, the Foundation evaluates more than 300 proposals annually.
Additional Details
August 31.2021

AACR Clinical Oncology Research (CORE) Training Fellowships
The AACR Clinical Oncology Research (CORE) Training Fellowships Program is designed to provide an effective industry-academic clinical practicum with a unique training opportunity to develop academic clinicians in drug development. Each fellowship provides $100,000 over one year for the fellow to work on site at the facility of one of AACR’s pharmaceutical industry partners. Time to be spent at the industry site over this one-year period can be flexible and is determined upon mutual agreement between the selected fellow, the fellow’s institution, and the industry partner. Indirect costs for up to a maximum of 20% of total direct costs are permitted.
Additional Details
August 31.2021

AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Fellowship
The AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Fellowship is a joint effort to support and encourage innovative research projects with direct applicability and relevance to ILC and to help establish a successful career path in the field.
Additional Details
September 23, 2021

AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants
The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants represents a joint effort to stimulate “high-risk, high-reward” research from early- to mid-career investigators. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice.
Additional Details
September 30, 2021

Foundation for the National Institutes of Health
Call for Clinical Trials for the Partnership for Accelerating Cancer Therapies (PACT)
Additional Details
Rolling basis through January 31, 2022

National Cancer Institute (NCI)
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments
Additional Details
Through May 8, 2022

*The VUMC Corporate & Foundation Relations team is happy to assist with proposal development for the above opportunities. Contact cfr@vumc.org for more information.